glp-1 news today obesity drug updates New research is challenging long-held assumptions about GLP GLP-1 Drugs: 6 Things We've
Description
doi: 10.1677/joe.1.06557
It has been demonstrated that semaglutide administered subcutaneously once weekly lowers HbA1c more effectively than liraglutide, dulaglutide, and exenatide once weekly [96]
Weight loss itself reduces blood pressure
The maximum FDA-approved semaglutide dose for weight loss is 2.4 milligrams, which generally produces less weight loss than tirzepatide fifteen milligrams
